From: Clinical analysis of 48 cases of malignant superior vena cava syndrome
 | Group 1 | Group 2 | Group 3 | Group 4 | P |
---|---|---|---|---|---|
Myelosuppression (%) | |||||
 I | 5 (50) | 4 (50) | 6 (27.3) | 2 (25) | 0.145 |
 II | 2 (20) | 1 (12.5) | 11 (50) | 2 (25) | |
 III | 0 (0) | 1 (12.5) | 1 (4.5) | 3 (37.5) | |
 IV | 0 (0) | 1 (12.5) | 1 (4.5) | 0 (0) | |
Anemia (%) | |||||
 Mild | 5 (50) | 3 (37.5) | 16 (72.7) | 5 (62.5) | 0.601 |
 Moderate | 3 (30) | 4 (50) | 5 (22.7) | 2 (25) | |
 Severe | 0 (0) | 0 (0) | 0 (0) | 1 (12.5) | |
Digestive tract reactions (%) | |||||
 I | 0 (0) | 2 (25) | 6 (27.3) | 3 (37.5) | 0.005* |
 II | 0 (0) | 6 (75) | 11 (50) | 2 (25) | |
Esophageal mucosal injury (%) | 1 (10) | 0 (0) | 10 (45.5) | 2 (25) | 0.131 |
Liver function abnormality | 0 (0) | 1 (12.5) | 10 (45.5) | 2 (25) | 0.389 |